SCM LifeScience Co

SCM LifeScience Co Debt

The Debt of SCM LifeScience Co (298060.KQ) as of Oct 10, 2026 is 3.18 B KRW. In the previous year, Debt was 3.69 B KRW — a change of -13.85% (lower).

Debt

3.18 BKRW

YoY

-13.85%

Last updated:

In 2024, SCM LifeScience Co's total debt was 3.18 B KRW, a -13.85% change from the 3.69 B KRW total debt recorded in the previous year.

The SCM LifeScience Co Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2017
8.00 B KRW
Jan 1, 2018
23.22 B KRW
Jan 1, 2019
6.59 B KRW
Jan 1, 2020
6.19 B KRW
Jan 1, 2021
81.12 M KRW
Jan 1, 2022
5.71 B KRW
Jan 1, 2023
3.69 B KRW
Jan 1, 2024
3.18 B KRW
The SCM LifeScience Co Debt history
YEARDebtYoY
3.18 BKRW-13.85%
3.69 BKRW-35.40%
5.71 BKRW+6,935.77%
81.12 MKRW-98.69%
6.19 BKRW-6.06%
6.59 BKRW-71.62%
23.22 BKRW+190.36%
8.00 BKRW—
Access this data via the Eulerpool API
Get Free API Key

SCM LifeScience Co Stock analysis

What does SCM LifeScience Co do? SCM LifeScience Co is one of the most popular companies on Eulerpool.

Debt Details

Understanding SCM LifeScience Co's Debt Structure

SCM LifeScience Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing SCM LifeScience Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to SCM LifeScience Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in SCM LifeScience Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about SCM LifeScience Co stock

Debt of SCM LifeScience Co is 3.18 B KRW in 2024.

Debt of SCM LifeScience Co changed from 3.69 B KRW to 3.18 B KRW, representing a -13.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt SCM LifeScience Co since 2006 – with annual values, charts, and detailed analysis.

Debt's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's SCM LifeScience Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — SCM LifeScience Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — SCM LifeScience Co